DISTAL RADIUS PLATING SYSTEM

K020819 · Biomet, Inc. · HRS · Apr 22, 2002 · Orthopedic

Device Facts

Record IDK020819
Device NameDISTAL RADIUS PLATING SYSTEM
ApplicantBiomet, Inc.
Product CodeHRS · Orthopedic
Decision DateApr 22, 2002
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Distal Radius Plating System is indicated for use in open reduction and internal fixation of Frykman type I-IV dorsally displaced Colles fractures, intomies, and carpal fusions of the distal radius in the presence of appropriate immobilization.

Device Story

Distal Radius Plating System consists of resorbable dorsal and volar plates used with 2.5mm resorbable screws; intended for orthopedic surgical fixation of distal radius fractures and fusions. Device provides mechanical stabilization of bone segments during healing process. Operated by orthopedic surgeons in clinical/surgical settings. Material is L-lactide/glycolide co-polymer. Benefit includes internal fixation without need for secondary hardware removal surgery due to resorbable nature of material.

Clinical Evidence

No clinical data was completed. Substantial equivalence supported by in-vitro mechanical testing and biocompatibility assessment.

Technological Characteristics

Resorbable bone fixation system; materials: L-lactide/glycolide co-polymer; components: dorsal/volar plates and 2.5mm screws; mechanical fixation principle; non-metallic; biocompatible.

Indications for Use

Indicated for patients requiring open reduction and internal fixation of Frykman type I-IV dorsally displaced Colles fractures, osteotomies, and carpal fusions of the distal radius, requiring concurrent immobilization.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## APR 2 2 2002 ## ARTERS CORPORA ## Summary of Safety and Effectiveness | Applicant or Sponsor: | Biomet, Inc.<br>P.O. Box 587<br>Warsaw, Indiana 46581-0587 | |-----------------------|------------------------------------------------------------| | Contact Person: | Michelle L. McKinley<br>Regulatory Specialist | | Proprietary Name: | Distal Radius Plating System | | Common or Usual Name: | plate system | | Classification Name: | Plate, fixation, bone (888.3030); | | Device Product Code: | HRS | Substantially Equivalent Device(s): Bionx Biodegradable Threaded Distal Radius Screw (K974876) , Resorbable Bone Pins (K011522) Device Description: The Distal Radius Plating System consists of resorbable dorsal and volates. The plates are used in conjunction with 2.5mm resorbable screws. The plates and screws are made of a L-lactide/glycolide co-polymer. Intended Use: The Distal Radius Plating System is indicated for use in open reduction and internal fixation of Frykman I-IV dorsally displaced Colles fractures, osteotomies, and carpal fusions of the distal radius in the presence of appropriate immobilization. Summary of Technologies: Extensive testing determined that the Distal Radius Plating System and Bionx Biodegradable Threaded Distal Radius Screw have equivalent mechanical properties. Biocompatibility testing was completed and demonstrated that the co-polymer material is non-toxic, non-mutagenic, and non-pyrogenic, Non-clinical Testing: In-vitro mechanical testing was completed and demonstrated that the Distal Radius Plating System was equivalent to the predicate devices. Clinical Testing: No clinical data was completed. MAILING ADDRESS P.O. Box 587 Warsaw, IN 46581-0587 1 SHIPPING ADDRESS 56 E. Bell Drive Warsaw, IN 46582 1 OFFICE 219.267.6639 I·AX 219.267.8137 E-MAIL biomet@biomet.com {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular emblem with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the top half of the circle. Inside the circle is a stylized image of an eagle with its wings spread, facing left. The eagle is composed of three thick, curved lines that suggest feathers. Public Health Service APR 2 2 2002 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Mary Verstynen Biomet, Inc. P.O. Box 587 Warsaw, IN 46581-0587 Re: K020819 Trade/Device Name: Distal Radius Plating System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: II Product Code: HRS Dated: January 31, 2002 Received: March 13, 2002 Dear Ms. Verstynen: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 -- Ms. Mary Verstynen This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely vours. Mark McMullen Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ | | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | | |--|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--| | | | | 510(k) Number (IF KNOWN): __K020819 Device Name: Distal Radius Plating System Indications for Use: The Distal Radius Plating System is indicated for use in open reduction and internal fixation of Frykman type I-IV dorsally displaced Colles fractures, intomies, and carpal fusions of the distal radius in the presence of appropriate immobilization. (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) OR Over-the-Counter Use Prescription Use A (Optional Format 1-2-96) (Per 21 CFR 801.109) ision Sign-Off) Division of General, Restorative and Neurological Devices 510(k) Number K020819
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%